Lung Cancer Drug Tabrecta Approved By The FDA — New Hope For People With a Specific Biomarker

Published May 7, 2020

Lung Cancer Drug Tabrecta Approved By The FDA — New Hope For People With a Specific Biomarker

The FDA's approval of Tabrecta marks a historic step in treatment for patients battling aggressive lung cancer. Researchers say this is just the beginning.

NOW
PLAYING
‘Saved by the Bell’ Star, Dustin Diamond, 44, Has Started Chemo for Stage 4 Small Cell Lung Cancer: How Is This Disease Treated?
NOW
PLAYING
Cancer Treatments Have Advanced at the Fastest Pace in History; From FDA Approvals to an Incredible Decrease In Death Rates
NOW
PLAYING
Seeking Human Decency-- CNN Anchor Asks People to Wish Radio Host Rush Limbaugh Well As He Fights Lung Cancer
NOW
PLAYING
Radio Host Rush Limbaugh, 69, Says He Could Travel for Cancer Treatments During COVID-19 Lockdown Because He Was Deemed ‘Essential’
NOW
PLAYING
As Rush Limbaugh Battles Advanced Lung Cancer, He Voices Profound Gratitude On-Air: "I’ve Got the Greatest Support System"
NOW
PLAYING
It's Been 19 Years Since The Beatles' George Harrison Passed From Throat & Lung Cancer; Some of the Incredible Medical Advances We've Seen Since

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.